baber/WOPTO huggingface dataset:
Patent DE-69601933-T2 (DE)
Inventor: BLAHO MIKLOS
IPC: G09F7/22
Filed: 1996-04-29
Granted: 1999-12-09
Abstract: The invention relates to an outdoor rotating display device which includes a stationary fastened hollow supporting frame and an information carrier element connected by means of a bearing device to the supporting frame to allow rotation in respect thereto, as well as an actuating unit accommodated within the inner hole of the supporting frame, said actuating unit composed of a driving sub-assembly and a motion transfer mechanism in connection with the driving sub-assembly, while the driving sub-assembly is connected through the motion transfer mechanism to the information carrier element. The characteristic feature of the invention is that at least either of the upper end (5a) and lower end (5b) of the motion transfer mechanism (5) is completed with a hinged coupling element (4) and a moment limiting sub-assembly (6) is inserted between the motion transfer mechanism (5) and the driving sub-assembly (7) and/or between the driving sub-assembly (7) and the information carrier element (2).
Patent DE-69605291-T2 (DE)
Inventor: WEIRICH DAVID
IPC: A61F13/53
Filed: 1996-02-14
Granted: 2000-05-11
Abstract: The present invention pertains to a compound sanitary napkin. The compound sanitary napkin comprises a primary absorbent member including an absorbent core and an outer cover. The primary absorbent member has a second portion and an first portion; the first portion being vertically opposed to the second portion. The width of the first portion is greater than the width of the second portion. The compound sanitary napkin further comprises a secondary absorbent member that is joined with the primary absorbent member juxtaposed the second portion. The secondary absorbent member preferably comprises a liquid impervious backsheet and an absorbent material joined thereto. Optionally, the secondary absorbent member includes a backsheet, a topsheet joined to the backsheet and an absorbent core disposed between the backsheet and the top sheet.
Patent DE-69614467-T2 (DE)
Inventor: COUPLAND KEITH
IPC: C09K23/00
Filed: 1996-03-11
Granted: 2002-03-28
Abstract: PCT No. PCT/GB96/00565 Sec. 371 Date Feb. 12, 1997 Sec. 102(e) Date Feb. 12, 1997 PCT Filed Mar. 11, 1996 PCT Pub. No. WO96/28436 PCT Pub. Date Sep. 19, 1996   <IMAGE>  (I)   <IMAGE>  (II)  Gamma and delta lactones of formulae (I and 11) are used as emulsifiers in explosive compositions comprising a continuous organic phase and a discontinuous aqueous phase containing an oxygen-supplying compound. In the formulae, R is hydrocarbyl, R* is hydrogen, methyl or another hydrocarbyl, and Q is an amide, ammonium salt or ester functionality.
Patent DE-69621532-T2 (DE)
Inventor: BARON LIONEL
IPC: A61B17/15
Filed: 1996-08-21
Granted: 2002-09-26
Abstract: The apparatus has a gantry frame (1) and two pairs of runners (21, 22; 31, 32) over and parallel to each other. They form trailing sections (21B, 22B; 31B, 32B) at the leading side of the frame, and leading sections (21A, 22A; 31A, 32A) on a plane at right angles to the frame. The leading and trailing sections of the lower pair (2) of runners are firmly fixed, and slide together in relation to the frame. The leading and trailing sections of the upper pair of runners (3) are not bonded, so that the leading sections (31A, 32A) of the upper pair can slide separately. The rear sections of the upper pair are both bonded to the frame.
Patent DE-69623933-T2 (DE)
Inventor: ROSENTHAL BRUCE A
IPC: G02B30/27
Filed: 1996-01-17
Granted: 2003-08-07
Abstract: A lenticular optical system is described in which a composite image is viewable through a lens sheet from a first angle and an object or image placed at a preselected distance beneath the composite image is viewable from a second angle. Optical designs and alignment processes are disclosed which make possible the economical production of thin materials which facilitate the manufacturing and utilization of the optical system in packaging and the like.
Patent DE-69627598-T2 (DE)
Inventor: SEINO SUSUMU
IPC: G01N33/577
Filed: 1996-09-17
Granted: 2003-11-13
Abstract: The present invention provides DNAs of h beta IR and m beta IR, which are novel ATP-sensitive potassium channels being present specifically in the pancreatic cells, and proteins encoded by such DNAs, wherein by utilizing them, it is possible to produce said proteins in large quantities through the known genetic engineering techniques for use as a reagent in the research work as well as in the diagnosis and therapy for diabetes and other diseases.
Patent DE-69629672-T2 (DE)
Inventor: NELSON RICHARD
IPC: G06T5/00
Filed: 1996-03-01
Granted: 2004-06-17
Abstract: This invention is an apparatus and method that is able to accurately measure the system level modulation transfer function in the presence of fixed pattern noise from an imaging system electronics.
Patent DE-69634843-T2 (DE)
Inventor: SARNGADHARAN MANGALASSERIL GOP
IPC: C12N5/0783
Filed: 1996-03-04
Granted: 2006-05-04
Abstract: A novel cell line chronically infected with HIV-2NIHZ virus secretes the precursor of the viral envelope proteins in extracellular medium. The cells grow well in serum-free medium which enables the concentration of the conditioned medium of the cells to be greatly increased (>100 fold). Such a concentration step is otherwise impossible to achieve if the cells are grown under conventional conditions using 10% fetal calf serum. A specific affinity procedure is provided to purify the gp160 protein from the concentrated conditioned medium of cultures of 100 liter batches using a mouse monoclonal antibody to the HIV-2 gp41 protein, which is a part of the gp160 protein. This purified HIV-2 gp160 reacts with high specificity and sensitivity with the anti viral antibodies of HIV-2 infected humans by several criteria such as i) ELISA, ii) western blot analysis, and iii) radioimmuno-precipitation of metabolically labeled gp160 from the same cell line. The purified HIV-2 gp160 from this cell line is therefore a diagnostic tool for the detection of HIV-2 infection in humans. In view of the predicted oligomeric property of gp160 and its close conformational similarity to the virion envelope, the purified gp160 can also be useful for the development of vaccine strategies against HIV-2 in humans.
Patent DE-69636900-T2 (DE)
Inventor: KAWASAKI HIDEKI
IPC: C12R1/865
Filed: 1996-12-27
Granted: 2007-11-22
Abstract: The present invention relates to a protein having the amino acid sequence represented by SEQ ID NO: 1, or a protein being capable of complementing the mutation exhibiting low-temperature-sensitive fermentability and having an amino acid sequence wherein one or more amino acid residues are added, deleted or substituted in the amino acid sequence represented by SEQ ID NO: 1; a gene which encodes said protein; and a gene which comprises DNA having the nucleotide sequence represented by SEQ ID NO: 1, or comprises DNA being capable of complementing the mutation exhibiting low-temperature-sensitive fermentability and having a nucleotide sequence wherein one or more DNAs are added, deleted or substituted in the nucleotide sequence represented by SEQ ID NO: 1. The present invention also relates to yeast belonging to the genus Saccharomyces and having low-temperature-sensitive fermentability which is characterized in that the above-mentioned gene on the chromosome is inactivated; dough containing said yeast; a process for making bread which comprises adding said yeast to dough; and a process for producing ethanol which comprises culturing said yeast in a medium, allowing ethanol to accumulate in the culture, and recovering ethanol from the culture.
Patent DE-69705896-T2 (DE)
Inventor: WANG SHU-ZHONG
IPC: C07D405/12
Filed: 1997-05-30
Granted: 2002-04-11
Abstract: An amorphous paroxetine hydrochloride is disclosed which is obtainable by spray drying a solution of the paroxetine hydrochloride. <IMAGE>
Patent DE-69709632-T2 (DE)
Inventor: DE BOER MARK
IPC: C07K14/705
Filed: 1997-02-21
Granted: 2002-08-08
Abstract: Methods for preventing or treating an antibody-mediated disease in patient are presented, the methods comprising administration of a humanized monoclonal antibody or fragment thereof that is capable of binding to a human CD40 antigen located on the surface of a human B cell, wherein the binding of the antibody to the CD40 antigen prevents the growth or differentiation of the B cell. Humanized monoclonal antibodies and fragments useful in these methods are also presented.
Patent DE-69709766-T2 (DE)
Inventor: HOPLEY IAN
IPC: B60N2/015
Filed: 1997-09-05
Granted: 2002-08-08
Abstract: This invention relates to methods of fastening seating to the floor of vehicles, and in particular to systems for allowing the seating to slide for adjustment or removal. Accordingly, a seating system is provided in which the longitudinal configuration and spacing of the seats may be more easily altered, without compromising safety. There is provided a seat anchorage system for seating carried in a vehicle including a track adapted to be attached to the load area of a vehicle, a traveller member configured to inter-engage with the track for longitudinal movement therealong and fixable to a seat, and securing means operative to permit securing of a seat associated with said traveller member in a desired position so as to prevent longitudinal movement of the seat. The traveller member is provided with longitudinally aligned bearings operative between the track and traveller member, the arrangement being such that the bearings maintain the traveller member aligned to facilitate longitudinal motion along said track.
Patent DE-69714274-T2 (DE)
Inventor: SHIRASAWA EIICHI
IPC: C07D307/935
Filed: 1997-09-12
Granted: 2003-03-27
Abstract: A fluorine-containing prostaglandin derivative of the formula (1) (or a salt thereof) and a medicine containing it, particularly, a preventive or therapeutic medicine for an eye disease: <CHEM> wherein A is a vinylene group, an ethylene group, an ethynylene group or the like, R<1> is an aryloxyalkyl group, an alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, an aralkyl group or the like, R<2> and R<3> are hydrogen atoms, acyl groups or the like, Z is OR<4>, -NHCOR<5>, -NHSO2R<6>, -SR<7>, (wherein R<4>, R<5>, R<6> and R<7> are hydrogen atoms, alkyl groups or the like) or the like, and a dual line consisting of solid and broken lines is a single bond, a cis-double bond or a trans-double bond. The medicine is an excellent medicine for an eye disease which has a high pharmacological action and little side effect.
Patent DE-69718046-T2 (DE)
Inventor: PEARSON JULITA
IPC: A23L27/30
Filed: 1997-09-16
Granted: 2003-05-22
Abstract: A directly compressible non-cariogenic free-flowing lactitol granulate comprising milled lactitol and a physiologically acceptable, binder taken from the group consisting of sugar alcohols, polymerized reducing sugars, alkali carboxymethylcellulose, hydrogenated starch hydrolysate, hydroxypropylcellulose, physiologically acceptable cellulose derivatives, polyvinylpyrrolidone, gum arabic, and other physiologically acceptable gums. The granulate is directly compressible, and manifests the taste profile, metabolic, and non-cariogenic properties of lactitol. In one embodiment, the milled lactitol is present in the granulate in the range of about 70% to about 98% by dry weight and the physiologically acceptable, non-cariogenic binder is present in the granulate in the range of about 2% to about 30% by dry weight. In a preferred embodiment of the invention, the granulate consists of 70-98% milled lactitol and 2-30% of a lactitol binder.
Patent DE-69718446-T2 (DE)
Inventor: CHAOUACHI JADELEDDINE
IPC: B28B3/02
Filed: 1997-10-23
Granted: 2003-10-23
Abstract: A hair-cutting system (1) is provided comprising a hair-cutting apparatus (2) having a toothed cutting device (17), and comprising a comb device (20) which can be mounted onto the hair-cutting apparatus (2) and comprises a stationary comb section (22) and an adjustable comb section (23), and comprising positioning means by which the adjustable comb section (23) can be positioned with respect to the stationary comb section (22), the stationary comb section (22) and the adjustable comb section (23) are loaded relative to one another by means of at least one spring (48), and the positioning means comprise an adjustment device (50) arranged on the hair-cutting apparatus (2), which adjustment device is adjustable to a number of settings by the hand in which the hair-cutting apparatus (2) is held during operation, and coupling means (51) are arranged between the adjustment device (50) and the adjustable comb section (23) for automatically coupling the adjustment device (50) and the adjustable comb section (23) when the comb device (20) is mounted onto the hair-cutting apparatus (2), and the adjustable comb section (23) is automatically movable into a desired operating position when the comb device (20) is mounted onto the hair-cutting apparatus (2).
Patent DE-69724964-T2 (DE)
Inventor: ZHAO ZHIYANG
IPC: A61K47/48
Filed: 1997-07-01
Granted: 2004-07-22
Abstract: The present invention relates to Glutathione S-transferase (GST)/Reduced Glutathione (GSH) as a means for the in-vivo release of a drug that has been conjugated to specific electrophilic moieties via a sulfonamide bond. The drug may be an anticancer agent (or one with other therapeutic properties) carrying a free -NH- which has been derivatized by the attachment of an electrophile containing a moiety, such as p-CN- or p-NO2-pyridinylsulfonyl groups, or p-NO2- or 2,4 dinitrophenylsulfonyl groups, or suitable derivatives thereof, to make a prodrug. Optionally, the sulfonamide moiety may have attached to it a targeting molecule. The present invention also provides Glutathione S-transferase (GST)/Reduced Glutathione (GSH) as a means for the release of a protected amino derivative that has been conjugated to specific electrophilic moieties via a sulfonamide bond. The precursor is a synthetic intermediate carrying a free -NH- which has been derivatized by the attachment of an electrophile via a sulfonamide bond.
Patent DE-69731786-T2 (DE)
Inventor: HEISLER GARY R
IPC: A61B17/32
Filed: 1997-04-10
Granted: 2005-04-28
Abstract: A rotating endoscopic shaver blade assembly adapted for side-cutting and end-cutting. A pair of longitudinally extending, symmetrical fingers (20 and 22) extends from the distal end of an elongated tubular inner member (14) and are juxtaposed adjacent a window at the distal end of an elongated tubular outer member. Each of the fingers is provided with laterally facing (39,40,42 and 43) and transversely facing (41 and 44) cutting edges and has a curvilinear profile terminating at a distal tip. The distal tips of the fingers are separated by an axially aligned gap (60) which enables limited stress-relieving radial movement of the fingers. <IMAGE>
Patent DE-69738483-T2 (DE)
Inventor: BERKA RANDY M
IPC: A23L11/30
Filed: 1997-03-18
Granted: 2008-12-11
Abstract: The present invention relates to isolated polypeptides having phytase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing the polypeptides. The present invention further relates to composite feeds and methods of reducing phytate levels.
Patent DE-69811161-T2 (DE)
Inventor: SHIMADA KAORU
IPC: C12Q1/26
Filed: 1998-07-27
Granted: 2003-06-12
Abstract: This invention relates to a method for evaluating the susceptibility of pharmaceutical drugs to metabolism by a specific cytochrome P-450 isozyme. which comprises contacting the sample compound with a reagent composition prepared by adding the specific cytochrome P-450 isozyme to liver microsomes lacking said specific cytochrome P-450 isozyme in a carrier material. More particularly, this invention relates to a useful in vitro quantitative assay for drug metabolism by P-450 isozymes such as CYP2D6, CYP2C19, and CYP2A6. This invention also relates to a reagent composition which is useful for said in vitro assay.
Patent DE-69814041-T2 (DE)
Inventor: BAER M
IPC: G02B21/32
Filed: 1998-02-05
Granted: 2004-01-22
Abstract: Systems and methods for laser capture microdissection are disclosed. One method incorporates the step of changing the beam diameter of the laser to adjust the size of the activated area of the transfer film and as a result, the size of the at least one microdissected portion of the sample adhered to the transfer film. Changing the beam diameter while operating the laser in idle mode permits the user to visualize the spot on the desired portion of the tissue sample and simultaneously increase or decrease the beam spot to optimally match the beam spot size with the portion of the tissue to be extracted. This method advantageously provides increased accuracy in microdissection and reduced heating of the tissue sample.
Patent DE-69818851-T2 (DE)
Inventor: SMITH ZELL
IPC: A61K8/06
Filed: 1998-08-07
Granted: 2004-07-29
Abstract: A wipe comprising a high internal phase inverse emulsion disposed in a discontinuous pattern on a substrate. The pattern provides areas coated with the emulsion and areas free of the emulsion. Preferably the emulsion is disposed so that the surface area to volume ratio of the emulsion is minimized. The emulsion locally expresses water during use upon the application of pressure to the wipe. The water is useful for cleaning. The discontinuous pattern of the emulsion provides regions of the substrate which are wetted during use and regions which may remain dry. The wetted regions transfer water to the surface to be cleaned. The dry regions then remove the water from the surface for more efficacious cleaning.
Patent DE-69823522-T2 (DE)
Inventor: PUHL MICHAEL
IPC: B31B50/16
Filed: 1998-02-05
Granted: 2005-04-07
Abstract: A cutting device for effecting a cut in a board-like fibrous material and densifying an area adjacent to the cut, includes a main body portion and a blade portion extending from the main body portion. The blade portion includes a cutting edge having first and second angled surfaces extending divergingly therefrom. A densifying member extends outwardly from at least one of the first and second angled surfaces. The densifying member compresses an area of the material adjacent to the cut as the blade is pressed into the material and densifies the adjacent area. The compression surface may be configured non-planar with an upper surface of the board-like material to selectively, variably densify the area adjacent to the cut.
Patent DE-69824015-T2 (DE)
Inventor: STUIVER HENDRIK
IPC: A01H5/00
Filed: 1998-06-29
Granted: 2004-09-23
Abstract: The invention provides novel Ti-plasmid vectors for Agrobacterium-medicated plant cell transformation. Plamsids of the invention are constructed with a DNA sequence (ie., a negative selectable maker or a DNA sequence that inhibits DNA unwinding) flanking the T-DNA bordered gene of interest that reduces or eliminates the occurrence of transformants with vector read-through DNA sequence. The invention also provides methods of plant cell transformation utilizing these novel vectors.
Patent DE-69837758-T2 (DE)
Inventor: AEGIDIUS POUL ERIK
IPC: G01N1/34
Filed: 1998-07-03
Granted: 2008-01-17
Abstract: A sample is aspirated into a Flow Injection Analysis (FIA) flow system, including a diffusion cell (20) and a measurement cell (30) arranged for determination of the component content (such as acetone). Before every new sample the two sides of the diffusion cell (20) are rinsed by the carrier fluids. In order to increase the sample cadence to about 250-500 samples per hour a pressure is established in communication with the carrier fluid conduits (36, 38), -the diffusion period includes the main part of the reaction period, the flow being stopped or slowed down for a predetermined period (e.g. 9.4 seconds) while the sample is staying in the diffusion cell (20), wherefore the reaction between the acceptor fluid and the component to be determined substantially occurs in the diffusion cell, -and the flow is controlled/regulated by timer-controlled hose clamp valves.
Patent DE-69905473-T2 (DE)
Inventor: GRIFFITHS CHARLES
IPC: C10G11/22
Filed: 1999-09-07
Granted: 2003-07-24
Abstract: A process for the production of olefins from a hydrocarbon comprising the steps of: a) providing a first feed stream comprising a gaseous fuel and an oxygen-containing gas; b) contacting the first feed stream with a first catalyst under conditions so as to produce a product stream and unreacted oxygen; c) providing a second feed stream of hydrocarbon feedstock; and d) contacting the second feed stream, the product stream of step b) and the unreacted oxygen step b) with a second catalyst which is capable of supporting oxidation, thereby consuming at least a part of the unreacted oxygen to produce an olefin product.
Patent DE-69914880-T2 (DE)
Inventor: HAYAMA TAKASHI
IPC: A61K31/435
Filed: 1999-01-18
Granted: 2004-08-05
Abstract: The present invention relates to a cyclopentenopyridine derivative represented by general formula (I) or a pharmaceutically acceptable salt thereof, wherein Ar is a phenyl group or the like. R1 is a mono- or di-C1-C6 alkylamino group or the like, and R2 is a hydroxyl group or the like, a process for its production and its use.
Patent DE-69922364-T2 (DE)
Inventor: DEL GIUDICE GIUSEPPE
IPC: A61K38/00
Filed: 1999-04-30
Granted: 2005-11-03
Abstract: Methods for treating and/or protecting H. pylori infection are described. The methods utilize non-mucosal administration of an effective amount of one or more H. pylori antigens.
Patent DE-69925621-T2 (DE)
Inventor: BERUBE DANY
IPC: A61B18/18
Filed: 1999-10-22
Granted: 2006-04-27
Abstract: A securing apparatus for selectively securing an ablating element of an ablation instrument proximate to a targeted region of a biological tissue. The securing apparatus includes a support base affixed to the ablation instrument relative the ablating element, and having a support face adapted to seat against the biological tissue proximate to the ablation element. The support base further defines a passage having one end communicably coupled to a vacuum source and an opposite end terminating at an orifice at the support face. The support face together with the biological tissue forms a hermetic seal thereagainst during operation of the vacuum source to secure the ablation instrument thereagainst. Essentially, the hermetic seal and the vacuum source cooperate to form a vacuum force sufficient to retain the ablation device against the biological tissue.